GeneReach Biotechnology

Name

GeneReach Biotechnology

Legal name

GeneReach Biotechnology Corp. (瑞基海洋生物科技股份有限公司)

Website

https://genereach.com

Company type

Public

Founded year

2004

Operating status

Operating

Headcount range

51–100 employees

Short description

GeneReach Biotechnology Corp. is a Taiwan-based molecular diagnostics company that designs, manufactures, and distributes point-of-care nucleic acid detection systems using proprietary insulated isothermal PCR (iiPCR) technology, serving aquaculture, veterinary, human diagnostics, food safety, and agriculture markets across 40+ countries via 30+ distributors.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics / In Vitro Diagnostics

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Medical and Diagnostic Laboratories (62151)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

akta.pro secondary industries

Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices) (AFALAEAK), Pathogen & Disease Diagnostics Services (Plant, Soil, Water) (AFACAKAG)

Keywords

• Point-of-care PCR diagnostics
• Nucleic acid analyzers
• Isothermal PCR technology
• Veterinary molecular diagnostics
• Aquaculture pathogen detection

Headquarters

HQ city

Taichung

HQ country

Taiwan

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Instrument Sales: Sale of nucleic acid detection instruments including POCKIT™ Central, POCKIT™ Micro Series, taco™ mini, and related equipment. Instruments are sold with 1-year warranty and include various throughput options (1-8 samples per run)
2. Reagents & Consumables: Recurring revenue from nucleic acid extraction reagents, iiPCR-specific reagents, IVD assays, and consumables. Includes taco™ DNA/RNA extraction kits (320 reactions/set), POCKIT reagents, and human IVD assays for diseases such as SARS-CoV-2 and Dengue
3. Training Services: Training programs and support services for product usage and applications

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

GeneReach develops, manufactures, and sells portable point-of-care nucleic acid detection instruments (POCKIT™ analyzers, taco™ extraction systems, cubee™ centrifuge) and proprietary iiPCR-based reagent kits and IVD assays. Its products enable rapid PCR-quality molecular diagnostics (~1 hour, 10-copy sensitivity) for aquaculture disease monitoring, veterinary point-of-care testing, human clinical diagnostics (e.g., SARS-CoV-2, Dengue), food safety, and agricultural pathogen screening, and are distributed globally through 30+ distributors.

Product overview

GeneReach Biotechnology offers a comprehensive point-of-care molecular diagnostics portfolio centered on its proprietary insulated isothermal PCR (iiPCR) technology. The core product line includes the POCKIT™ Central automated analyzer and POCKIT™ Micro Series handheld analyzers, which work in conjunction with the taco™ nucleic acid extraction systems (mini and standard models) and various reagent kits. The product ecosystem spans human IVD assays (including SARS-CoV-2 and Dengue), aquaculture disease detection (IQ2000™ and IQ REAL™ systems), and veterinary diagnostics. All products are manufactured under ISO 13485 and GMP quality management systems, with applications across human health, aquaculture, agriculture, food safety, and companion animal industries.

Differentiator

Problem solved

Functional benefit

Brands

• POCKIT: Point-of-care nucleic acid detection platform including POCKIT Central, POCKIT Micro Series, and POCKIT combo mobile laboratory
• taco
• cubee
• IQ2000
• IQ REAL

Products and services

• POCKIT™ Central Nucleic Acid Analyzer

Quantifiable outcome

• Detection sensitivity up to 10 copies per reaction, equivalent to real-time PCR
• +3 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Global Distributor NetworkcoreChannel Partner/ Reseller/ DistributorGeneReach has established partnerships with more than 30 distributors worldwide to provide local sales support, technical assistance, and product distribution across different regions including Asia, Americas, Europe, Middle East, and Australia. These distributor partnerships enable market access and customer support in local languages and geographies.

Scale indicators4 records

Direct peers

• BioMérieux (BioFire): Operates the BioFire FilmArray multiplex PCR panels, a leading syndromic molecular diagnostics franchise. Comparable on PCR-based IVD for infectious disease and on the razor-and-blade reagent model used by GeneReach.
• IDEXXX Laboratories: Global leader in veterinary diagnostics with a strong molecular and point-of-care franchise (e.g., SNAP, RealPCR). Comparable to GeneReach's veterinary/animal-health segment where IDEXX is the dominant reference-lab and in-clinic provider.
• Cepheid (Danaher): Maker of the GeneXpert point-of-care PCR system, the dominant cartridge-based molecular diagnostics platform in clinical and decentralised settings. Directly comparable to GeneReach on instrument-plus-cartridge architecture and CLIA-waivable point-of-care positioning.

Regional players

• Seegene: Korea-based developer of multiplex real-time PCR assays (Allplex), with overlapping infectious-disease menu and syndromic testing ambitions. Comparable on PCR-based human IVD reagents, although Seegene is oriented toward high-throughput labs rather than point-of-care.
• SD Biosensor: Korea-headquartered diagnostics company spanning rapid antigen tests, molecular diagnostics and clinical chemistry. Comparable on the molecular infectious-disease menu and on a regional Asian distribution model similar to GeneReach's.

Broad incumbents

• Bio-Rad Laboratories: Long-established PCR and droplet digital PCR (ddPCR) franchise plus clinical diagnostics business. Comparable on the underlying PCR instrumentation and reagents that GeneReach's iiPCR competes with at the benchtop and high-sensitivity tier.
• Thermo Fisher Scientific: Owns Applied Biosystems PCR instruments, MagMAX extraction kits and the Mesa Biotech Accula portable PCR platform acquired during COVID-19. Comparable across almost every layer of GeneReach's stack: instruments, extraction, reagents, and emerging point-of-care molecular.
• Zoetis: Largest pure-play animal health company with diagnostics, vaccines and pharma. Comparable on the livestock and companion-animal customer base that GeneReach serves through POCKIT veterinary assays.
• Abbott Diagnostics: Markets the ID NOW and m-PIMA systems, isothermal/portable molecular platforms that compete directly with POCKIT in rapid point-of-care nucleic acid testing; broader portfolio and distribution reach give Abbott structural pricing advantages.

Emerging players

• Molbio Diagnostics: India-based maker of the Truenat point-of-care real-time PCR platform, focused on resource-limited settings and tuberculosis/HIV testing. Comparable on portable PCR hardware, low-infrastructure positioning, and emerging-market go-to-market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@pockitcentralmoleculartest3885

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GeneReach Biotechnology